1[1]Couillard S, Labrie C, Gauthire S ,et al. Long- term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice[J]. Int J Cancer,2000; 85:424 - 429.
2[2]Clarke R. Human breast cancer cell line xenografts as models of breast cancer--The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines[J].Breast Cancer Res Treat, 1996; 39:69-86.
3[3]Kozlowski JM, Fidler I J, Campbell D et al. Metastatic behavior of human tumor cell lines grown in the nude mouse[J]. Cancer Research, 1984; 44:3522 - 3529.
4[4]Mehta RR, Graves JM, Hart GD et al. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice[J]. Breast Cancer Res Treat, 1993; 25:65 - 71.
5[5]Hurst J, Maniar N, Tombarkiewicz J, et al. A novel model of a metastatic human breast tumour xenograft line[J].Br J Cancer, 1993; 68:274- 276.
6[6]Rae- Venter B, Reid LM. Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture[J]. Cancer Resareh 1980; 40:95- 100.
7[7]Engel LW, Young NA, Tralka TS et al. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas [J]. Cancer Research, 1978;38: 3352 - 3364.
8[8]Alpaugh ML, Tomlinson JS, Shao ZM, et al. A novel human xenograft model of inflammatory breast cancer[J]. Cancer Researsh, 1999; 59: 5079 - 5084.
9[9]Giovanella BC, Vardeman DM, Willams LJ, et al, Heterotransplantation of human breast carcinomas in nude mice.correlation between successful heterotransplants, poor prognosis and amplification of the Her- 2/neu oncogene[J]. Int J Cancer, 1991; 47:66-71.
10[10]Price JE, Polyzos A, Zhang RD, et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice[J]. Cancer Research, 1990; 50:717- 721.
4Jemal A, Siegel R, Ward E, et al. Cancer statistics [ J ]. CA Cancer J Clin, 2008, 58(2) : 71 -96.
5Ross JS, Fletccher JA. The HER - 2/neu oncogene: prognostic factor, predictive factor and target for therapy [J]. Semin Cancer Biol, 1999, 9(2): 125 -138.
6Park JW, Hong K, Kirpotin DB, et al. Anti - HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery[J]. Clin Cancer Res, 2002, 8 (4): 1172 - 1181.
7Passaniti A, Taylor RM, Pili R, et al. A simple, quantitative method for assessing angiogenesis and anti - angiogenic agents using reconstituted basement membrane, heparin, and fihroblast growth factor[J]. Lab Invest, 1992, 67(4) : 519 -528.
8Kozlowski JM, Fidler IJ, Campbell D, et al. Metastatic behavior of human tumor cell lines grown in the nude mouse[J]. Cancer Res, 1984, 44(8): 3522 -3529.
9Judge AD, Robbins M, Tavakoli I, et al. Confirming the RNAi - mediated mechanism of action of siRNA - based cancer therapeutics in mice [ J ]. J Clin Invest, 2009, 119 (3) : 661 -673.
10Yu F, Yan H, Zhu P, et al. 1 et - 7 regulates self - renewal and tumorigenesis of breast cancer cells [ J ]. Cell, 2007, 131(6): 1109-1123.
